Home › Castration-Resistant Prostatic Cancer › Nebraska
Castration-Resistant Prostatic Cancer clinical trials in Nebraska
3 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in Nebraska.
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- NHO Revive Research Institute, LLC, Lincoln
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- XCancer Omaha / Urology Cancer Center, Omaha
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT0716444364Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
- XCancer, Omaha
RecruitingPhase 1/2
Ages 18 and older · Men · Updated May 6, 2026 · NCT04868604From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.